Background illustration for clinical trials search

Paid Clinical Trials Waterbury

Discover 1,161 paid clinical trials in Waterbury, Connecticut. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Lifestyle, Exercise, And Nutrition (LEAN) Trial on Pathologic Complete Response in TNBC

for
Triple Negative Breast Cancer
Location: New Haven CT
Sponsor: Yale University

Sex: Female

Age: 18+

Code: NCT07066189

Recruiting

Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer

for
Buccal Mucosa Squamous Cell Carcinoma,
Location: New Haven CT, Trumbull CT, Harrison NY, Commack NY,
Sponsor: NRG Oncology

Sex: All

Age: 18+

Code: NCT04333537

Phase 2, Phase 3, Recruiting

Exploring Water-free Sodium Storage

for
Peritoneal Dialysis, Heart Failure
Location: New Haven CT
Sponsor: Yale University

Sex: All

Age: 18+

Code: NCT06872645

Recruiting

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

for
Ganglioneuroblastoma, Ganglioneuroblastoma, Nodular,
Location: New Haven CT, Hartford CT, Stony Brook NY, Valhalla NY,
Sponsor: Children's Oncology Group

Sex: All

Age: 1 - 30

Code: NCT03126916

Phase 3, Recruiting

RESTORE Study R61 Phase: Recovery and Engagement for Stimulant Users on Re-entry

for
HIV, Stimulant Use Disorder, Justice Involved Populations,
Location: New Haven CT, Dallas TX
Sponsor: University of Texas Southwestern Medical Center

Sex: All

Age: 18+

Code: NCT07136363

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )

for
Pancreatic Cancer, Pancreatic Cancer Metastatic, PDAC,
Location: New Haven CT, New York NY, New Brunswick NJ,
Sponsor: Revolution Medicines, Inc.

Sex: All

Age: 18+

Code: NCT07621718

Phase 3, Recruiting

Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

for
Alzheimers Disease
Location: New Haven CT, Laurelton NY, New York NY, Ridgewood NJ,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 50 - 70+

Code: NCT07177352

Phase 3, Recruiting

CUE-101with Pembrolizumab for Locally Advanced HPV+HNSCCs

for
Head and Neck Squamous Cell Carcinoma,
Location: New Haven CT
Sponsor: Yale University

Sex: All

Age: 18+

Code: NCT07172256

Phase 2, Recruiting

A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors

for
Advanced Solid Tumor
Location: New Haven CT, Hartford CT, New York NY, Boston MA,
Sponsor: BioNTech SE

Sex: All

Age: 18+

Code: NCT07070232

Phase 1, Phase 2, Recruiting

First-in-Human Study of ADCE-B05 in Patients With Advanced Solid Tumors

for
Solid Tumors (Phase 1)
Location: New Haven CT, Springdale AR, Houston TX
Sponsor: Adcendo ApS

Sex: All

Age: 18+

Code: NCT07362888

Phase 1, Recruiting

Engaging T-cells to Eliminate MRD in Newly Diagnosed Myeloma Optimizing Response With Talquetmab and Teclistamab (ROTATE)

for
Multiple Myeloma
Location: New Haven CT, Rochester NY, Omaha NE
Sponsor: Noffar Bar

Sex: All

Age: 18+

Code: NCT06993675

Phase 2, Recruiting

Merck IIT: RRP Pembro and Lenvatinib

for
Human Papilloma Virus, Recurrent Respiratory Papillomatosis,
Location: New Haven CT
Sponsor: Yale University

Sex: All

Age: 18+

Code: NCT04645602

Phase 2, Recruiting

AB821 in Adult Participants With Locally Advanced or Metastatic Solid Tumors

for
Advanced Melanoma and Normal or Impaired, Advanced Melanoma
Location: New Haven CT
Sponsor: Yale University

Sex: All

Age: 18+

Code: NCT07027488

Phase 1, Recruiting

tDCS for Laryngeal Dystonia

for
Laryngeal Dystonia
Location: New Haven CT
Sponsor: Yale University

Sex: All

Age: 18 - 65

Code: NCT06830174

Recruiting

Impact of Omitting Chemo Based on Patient's Selection for ER-Positive, HER2-Negative Breast Cancer With Ribociclib and Endocrine Therapy

for
HER2 Negative Breast Cancer
Location: New Haven CT
Sponsor: Yale University

Sex: All

Age: 18+

Code: NCT06953882

Phase 2, Recruiting

ARTIST: Aortic Regurgitation Trial Investigating Surgery Versus Trilogy™

for
Aortic Regurgitation, Aortic Valve Insufficiency,
Location: New Haven CT, New York NY, New Brunswick NJ, Boston MA,
Sponsor: JenaValve Technology, Inc.

Sex: All

Age: 0+

Code: NCT06608823

Recruiting

A Clinical Study to Test if an Investigational Treatment Called BNT314 When Used in Combination With Another Investigational Treatment Pumitamig (BNT327) and Chemotherapy, is Beneficial and Safe for Patients With Advanced Colorectal Cancer

for
Metastatic Colorectal Cancer
Location: New Haven CT, Cleveland OH, Grand Rapids MI, Houston TX
Sponsor: BioNTech SE

Sex: All

Age: 18+

Code: NCT07079631

Phase 1, Phase 2, Recruiting

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

for
B Acute Lymphoblastic Leukemia
Location: New Haven CT, Hartford CT, Stony Brook NY, Valhalla NY,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 1 - 46

Code: NCT06124157

Phase 2, Recruiting

A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis

for
Recurrent Langerhans Cell Histiocytosis,
Location: New Haven CT, Hartford CT, The Bronx NY,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 0 - 22

Code: NCT05828069

Phase 2, Recruiting

Circulating Tumor DNA

for
ER+ Breast Cancer
Location: New Haven CT, The Bronx NY, Boston MA, Baltimore MD,
Sponsor: Yale University

Sex: All

Age: 18+

Code: NCT06923527

Phase 2, Recruiting